Enterin's Series A Round

Enterin raised a round of funding on July 13, 2017. Investors include New Ventures Funds.

Enterin is a biotechnology company developing novel compounds that repair the dysfunctional gut-brain axis in patients with neurodegenerative diseases, such as Parkinson's disease (PD). The lead compo…

Articles about Enterin's Series A Round: